Buyer Guide,are recognisable by hAMPA

Acetyl-lysine peptide antibody research is a rapidly advancing field, offering crucial tools for understanding the intricate world of protein modifications. These specialized antibodies are designed to detect proteins post-translationally modified by acetylation, a fundamental process that profoundly influences protein function, stability, and cellular interactions. The ability to precisely identify and quantify these modifications is paramount for researchers delving into various biological pathways, making the acetylated peptide antibody an indispensable reagent.

At its core, acetylation involves the addition of an acetyl group to the epsilon-amine group of lysine residues. This post-translational modification (PTM) can occur on a vast array of proteins, including histones and non-histone proteins, playing critical roles in processes such as gene regulation, signal transduction, and metabolic control. The development of antibodies that specifically target acetylated lysine residues has revolutionized the study of these dynamic changes. For instance, the Acetylated-Lysine Antibody #9441 from Cell Signaling Technology is engineered to recognize proteins modified by acetylation on the epsilon-amine groups of lysine residues, providing a reliable method for their detection. Similarly, other antibodies, like the Acetylated Lysine Monoclonal Antibody (1C6), have demonstrated efficacy in detecting a ladder of acetylated proteins in HeLa cell lysate via Western blot, showcasing their utility in complex biological samples.

The development of these antibodies often relies on immunizing animals with specific antigens, such as chemically acetylated ovalbumin and synthetic acetylated peptide conjugates. This approach, detailed in research by Guan et al. (2010), has been instrumental in generating pan-acetyl-lysine antibodies capable of recognizing a broad spectrum of acetylated targets. Researchers can generate these antibodies through various protocols, including those that utilize acetyl-lysine peptide as a crucial component. These peptides often represent the epitope recognized by the antibody, and their use in blocking assays can confirm antibody specificity.

The applications of acetylated peptide antibody are diverse and expanding. They are instrumental in techniques such as Western blotting (WB), immunofluorescence (IF), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). For example, a Rabbit Polyclonal acetyl Lysine antibody (like ab80178) is suitable for multiple applications, including IP, ELISA, WB, IHC-P, and ICC/IF, and has been cited in numerous publications, underscoring its broad utility. These antibodies are essential for researchers aiming to detect changes in protein acetylation levels, thereby gaining insights into the active state of proteins and their regulatory mechanisms.

Furthermore, the specificity of these antibodies can be tailored. While some are pan-acetylation and site-specific acetylation antibodies that recognize a wide range of acetylated lysine residues, others are designed for more precise targeting. For instance, antibodies that detect N-terminal acetylation are crucial for studying this specific modification, which is known to be a strategic modification that profoundly influences biological activity, stability, and cellular interactions. Research into N-terminal acetylation status of cellular proteins often employs such specialized reagents.

The significance of acetylation extends to various biological contexts. Acetylated bacterial proteins, for example, have been shown to be recognizable by specific immune components and capable of inducing cross-reactive responses. Understanding these interactions is vital for infectious disease research and vaccine development.

In summary, the acetylated peptide antibody is a powerful tool for biological research, enabling scientists to detect proteins containing acetylated lysine residues with high specificity. Whether investigating fundamental cellular processes like gene regulation or exploring disease mechanisms, these antibodies provide critical insights into the dynamic world of protein acetylation. The continued development of novel and highly specific antibodies, including pan-acetylation and site-specific acetylation antibodies, will undoubtedly further advance our understanding of this essential post-translational modification. The ability to measure acetylation and deacetylation activity, aided by these remarkable antibodies, is key to unraveling complex biological puzzles.